|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0011065,
umls-concept:C0013018,
umls-concept:C0021368,
umls-concept:C0023884,
umls-concept:C0023911,
umls-concept:C0023981,
umls-concept:C0025815,
umls-concept:C0087111,
umls-concept:C0282440,
umls-concept:C0332161,
umls-concept:C0392756,
umls-concept:C1096777,
umls-concept:C1274040,
umls-concept:C1527169,
umls-concept:C1549464,
umls-concept:C1704456
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-12-18
|
|
pubmed:abstractText |
To investigate potential beneficial effects of donor treatment with methylprednisolone on organ function and outcome after liver transplantation.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1528-1140
|
|
pubmed:author |
pubmed-author:FaberWW,
pubmed-author:FrancuskiMM,
pubmed-author:FrankUlrichU,
pubmed-author:HoffmanSS,
pubmed-author:KohlerSS,
pubmed-author:KotschKatjaK,
pubmed-author:KuecuekOO,
pubmed-author:KunertCC,
pubmed-author:LuxKK,
pubmed-author:NeuhausPP,
pubmed-author:PascherAndreasA,
pubmed-author:PratschkeJohannJ,
pubmed-author:Reutzel-SelkeAnjaA,
pubmed-author:SchumacherGG,
pubmed-author:TulliusS GSG,
pubmed-author:WarnickPP,
pubmed-author:WeissSS,
pubmed-author:WesslauCC
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
248
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1042-50
|
|
pubmed:dateRevised |
2011-9-2
|
|
pubmed:meshHeading |
pubmed-meshheading:19092349-Adult,
pubmed-meshheading:19092349-Aged,
pubmed-meshheading:19092349-Anti-Inflammatory Agents,
pubmed-meshheading:19092349-Brain Death,
pubmed-meshheading:19092349-Chemokine CCL2,
pubmed-meshheading:19092349-Female,
pubmed-meshheading:19092349-Humans,
pubmed-meshheading:19092349-Inflammation,
pubmed-meshheading:19092349-Interleukin-2,
pubmed-meshheading:19092349-Interleukin-2 Receptor alpha Subunit,
pubmed-meshheading:19092349-Interleukin-6,
pubmed-meshheading:19092349-Interleukins,
pubmed-meshheading:19092349-Liver,
pubmed-meshheading:19092349-Liver Transplantation,
pubmed-meshheading:19092349-Male,
pubmed-meshheading:19092349-Methylprednisolone,
pubmed-meshheading:19092349-Middle Aged,
pubmed-meshheading:19092349-Postoperative Period,
pubmed-meshheading:19092349-Prospective Studies,
pubmed-meshheading:19092349-Reperfusion Injury,
pubmed-meshheading:19092349-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:19092349-Tissue Donors,
pubmed-meshheading:19092349-Treatment Outcome,
pubmed-meshheading:19092349-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial.
|
|
pubmed:affiliation |
Institute of Medical Immunology, Charité, Universitätsmedizin Berlin, Berlin, Germany.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
